All In Biotech

Drug Trial Radar · NCT06024642

Study of V117957 in Overactive Bladder Syndrome

Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Overactive Bladder Syndrome

Last checked: Nov 19, 2026Latest source record: Jun 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

51

Actual

Start

Jun 30, 2022

Primary completion

May 21, 2024

Study completion May 21, 2024

Sponsor

Lead sponsor
Imbrium TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Purdue Pharma LP
First posted
Sep 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with overactive bladder syndrome, compared to placebo.

Conditions

  • Overactive Bladder Syndrome

Interventions

  • V117957Drug

    V117957 1 mg - 1 tablet taken orally at bedtime.

  • PlaceboDrug

    Placebo to match V117957 tablets - 1 tablet taken orally at bedtime.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Micturition Episode Components (Micturition, Incontinence, and Urgency) Per 24 Hours.Time frame: Baseline, Weeks 2, and 8

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Urology Specialists, PLLC

    Tucson, Arizona

  • Hope Clinical Research, LLC

    Canoga Park, California

  • ARK Clinical Research

    Long Beach, California

  • Urology Group of Southern California

    Los Angeles, California

  • Providea Health Partners, LLC

    Evergreen Park, Illinois

  • DelRicht Research

    New Orleans, Louisiana

  • Ochsner LSU Health Shreveport - Regional Urology

    Shreveport, Louisiana

  • Boston Clinical Trials

    Boston, Massachusetts

  • Bay State Clinical Trials, Inc.

    Watertown, Massachusetts

  • AccuMed Research Associates

    Garden City, New York

  • Unified Women's Clinical Research-Lyndhurst

    Winston-Salem, North Carolina

  • The Clinical Trial Center, LLC

    Jenkintown, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.